Canadian Policy Challenges for Psychedelic Therapy in Cancer Care

Fragmented Governance in Canadian Psychedelic Therapy

Policy fragmentation in Canada could hinder the implementation of psychedelic-assisted therapy (PAT) in cancer care systems. Despite existing federal access mechanisms, the lack of clear governance and coordination across federal, provincial, and professional bodies presents challenges. This fragmentation creates uncertainty around training standards, reimbursement, service delivery models, accountability, and equity considerations.

Currently, governance responsibilities for PAT are distributed among federal regulators, provincial health systems, professional colleges, cancer agencies, and clinical organizations. This decentralized approach complicates the integration of PAT into existing cancer care systems, despite the growing clinical evidence supporting its efficacy for conditions such as existential distress, demoralization, depression, and anxiety among cancer patients.

Existing Access Mechanisms and Policy Gaps

Canada has established federal access pathways for PAT, including clinical trials and the Special Access Program. However, these mechanisms primarily focus on individual access rather than system-wide integration. The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) highlights that while access pathways exist, the readiness of health systems to govern, integrate, and scale these therapies remains a significant challenge.

Addressing these gaps requires coordinated stakeholder engagement and the development of clear implementation guidance. This includes clarifying roles and responsibilities among various stakeholders and ensuring proactive equity planning to prevent disparities in access and outcomes.

Risks and Unknowns in Policy Implementation

The central challenge facing PAT implementation in Canada is not the lack of access pathways but whether health systems are prepared to integrate these therapies responsibly. Without clear governance structures, there is a risk of inconsistent practices, which could undermine the safety and efficacy of PAT in cancer care.

Furthermore, the lack of coordinated policy development could lead to inequities in access, with some regions or populations potentially being underserved. As demand for PAT grows, these risks could become more pronounced, necessitating urgent policy attention.

Opportunities for Strengthening Policy Readiness

Opportunities exist to strengthen policy readiness for PAT integration in Canada through stakeholder engagement, development of implementation guidance, and knowledge mobilization activities. Engaging health system decision-makers, regulators, clinicians, and patient partners can help align emerging clinical evidence with policy frameworks.

By proactively addressing policy fragmentation, Canada can better position itself to integrate PAT into cancer care systems, ensuring that these therapies are delivered safely, equitably, and effectively as clinical evidence continues to mature.